CEL-SCI Corp. (CVM)
1.21
-0.26
(-17.69%)
USD |
NYAM |
Nov 20, 16:00
1.20
-0.01
(-0.83%)
Pre-Market: 20:00
CEL-SCI Price : 1.21 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | 1.535 | 1.59 | 1.185 | 1.21 | 880307.0 |
| Nov 19, 2026 | 1.46 | 1.51 | 1.38 | 1.47 | 267066.0 |
| Nov 18, 2026 | 1.70 | 1.71 | 1.335 | 1.38 | 615783.0 |
| Nov 17, 2026 | 1.86 | 2.14 | 1.73 | 1.85 | 1.489M |
| Nov 16, 2026 | 1.32 | 1.75 | 1.30 | 1.66 | 1.168M |
| Nov 13, 2026 | 1.19 | 1.28 | 1.145 | 1.28 | 145748.0 |
| Nov 12, 2026 | 1.33 | 1.35 | 1.19 | 1.19 | 150505.0 |
| Nov 11, 2026 | 1.41 | 1.43 | 1.28 | 1.31 | 87970.00 |
| Nov 10, 2026 | 1.44 | 1.50 | 1.33 | 1.41 | 128553.0 |
| Nov 09, 2026 | 1.45 | 1.53 | 1.35 | 1.35 | 53929.00 |
| Nov 06, 2026 | 1.37 | 1.45 | 1.338 | 1.45 | 46675.00 |
| Nov 05, 2026 | 1.39 | 1.431 | 1.28 | 1.37 | 99185.00 |
| Nov 04, 2026 | 1.41 | 1.46 | 1.38 | 1.38 | 27887.00 |
| Nov 03, 2026 | 1.31 | 1.41 | 1.24 | 1.41 | 215691.0 |
| Nov 02, 2026 | 1.39 | 1.44 | 1.30 | 1.31 | 91939.00 |
| Oct 30, 2026 | 1.49 | 1.49 | 1.36 | 1.38 | 189970.0 |
| Oct 29, 2026 | 1.56 | 1.64 | 1.50 | 1.50 | 78382.00 |
| Oct 28, 2026 | 1.540 | 1.62 | 1.52 | 1.60 | 99402.00 |
| Oct 27, 2026 | 1.58 | 1.60 | 1.46 | 1.57 | 117639.0 |
| Oct 26, 2026 | 1.71 | 1.83 | 1.510 | 1.59 | 106855.0 |
| Oct 23, 2026 | 1.59 | 1.64 | 1.574 | 1.64 | 41897.00 |
| Oct 22, 2026 | 1.61 | 1.652 | 1.58 | 1.61 | 79354.00 |
| Oct 21, 2026 | 1.56 | 1.62 | 1.50 | 1.62 | 149412.0 |
| Oct 20, 2026 | 1.65 | 1.661 | 1.54 | 1.55 | 140469.0 |
| Oct 19, 2026 | 1.79 | 1.81 | 1.60 | 1.65 | 130172.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 5.97 |
| Amgen, Inc. | 435.64 |
| Anika Therapeutics, Inc. | 13.23 |
| BioCryst Pharmaceuticals, Inc. | 7.22 |
| Imunon, Inc. | 0.5355 |
Price Related Metrics
| Price to Book Value | 1.943 |
| Earnings Yield | -213.5% |
| Market Cap | 21.28M |